NCT06661681 Cognitive Functional Therapy for Treating Individuals With Chronic Shoulder Pain
| NCT ID | NCT06661681 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Federal University of Paraíba |
| Condition | Chronic Shoulder Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 72 participants |
| Start Date | 2025-02-17 |
| Primary Completion | 2026-06-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 72 participants in total. It began in 2025-02-17 with a primary completion date of 2026-06-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Shoulder pain is a debilitating musculoskeletal condition with functional, physical, and psychological impacts. Interventions for chronic shoulder pain should address the biopsychosocial model, with Cognitive Functional Therapy emerging as a promising physiotherapy approach. Cognitive Functional Therapy approaches the multidimensional nature of pain, integrating physical and cognitive aspects. The aim of this randomized controlled trial is to compare the effects of Cognitive Functional Therapy with therapeutic exercise on biological aspects of pain (pain intensity, disability, function, perception of improvement/deterioration, and central pain processing), and psychosocial aspects of pain (sleep quality, self-efficacy, and biopsychosocial factors). The hypothesis of this study is that CFT will lead to greater improvements in these outcomes compared to therapeutic exercise.
Eligibility Criteria
Inclusion Criteria: * Men or women; * Age between 18 and 60 years; * Presence of shoulder pain for more than 3 months; * Pain intensity of 4 points or more on the 11-point Numeric Pain Rating Scale. * High level of disability or moderate level of irritability. Exclusion Criteria: * History of fracture or surgery of the clavicle, scapula, and/or humerus, surgical stabilization or rotator cuff repair; * History of dislocation, instability (positive sulcus sign or apprehension test), and/or rotator cuff tear (positive drop arm test); * Adhesive capsulitis verified by the presence of gradual onset pain associated with stiffness and reduced passive and active mobility; * Ongoing pregnancy; * Reproduction of shoulder pain radiating to the entire upper limb during cervical or thoracic spine tests (positive Spurling test); * Neurological or systemic diseases that may alter muscle strength and sensitivity such as rheumatoid arthritis, fibromyalgia, lupus, gout, and diabetes; * Corticosteroid injection in the shoulder region in the last 3 months; * Physiotherapy treatment in the last 6 months. * Active treatment for cancer
Contact & Investigator
Danilo H Kamonseki, PhD
PRINCIPAL INVESTIGATOR
Universidade Federal da Paraíba
Frequently Asked Questions
Who can join the NCT06661681 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Chronic Shoulder Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06661681 currently recruiting?
Yes, NCT06661681 is actively recruiting participants. Contact the research team at danilo.kamonseki@academico.ufpb.br for enrollment information.
Where is the NCT06661681 trial being conducted?
This trial is being conducted at João Pessoa, Brazil.
Who is sponsoring the NCT06661681 clinical trial?
NCT06661681 is sponsored by Federal University of Paraíba. The principal investigator is Danilo H Kamonseki, PhD at Universidade Federal da Paraíba. The trial plans to enroll 72 participants.